What is Axsome Therapeutics Inc (AXSM)?
Axsome Therapeutics Inc is a biopharmaceutical company engaged in the development and commercialization of novel therapies for central nervous system disorders. The company focuses on addressing unmet medical needs in areas such as depression, migraine, and other neurological conditions. Axsome Therapeutics Inc conducts clinical research to advance its pipeline of drug candidates, employing innovative mechanisms of action and delivery methods. Its development programs include both small molecule therapeutics and other pharmaceutical modalities. The company operates within the regulatory frameworks governing drug approval and commercialization, collaborating with healthcare providers and regulatory agencies. Axsome Therapeutics Inc aims to contribute to medical science by developing treatments that improve patient outcomes and quality of life.
Axsome Therapeutics Inc Stock Price Today: Live Overview
The price today is shaped by market session movements, with Axsome Therapeutics Inc trading at $156.94. The intraday range extends from $153.4 to $158.55, showing a daily change of +0.0255%.
FAQ: Axsome Therapeutics Inc (AXSM)
What is the current price of AXSM stock?
The last traded price is $156.94.
Does AXSM pay dividends?
The company does not currently pay dividends.
Does AXSM have a formal corporate presence or regional headquarters in the UAE?
Axsome Therapeutics Inc has no official regional office or subsidiary in the UAE and operates through partners only.
What is AXSM best known for?
The company is most famous for developing central nervous system therapies.
What assets are typically shown together with AXSM?
Commonly shown alongside AXSM: Dauch Corporation, Amundi MSCI Brazil UCITS ETF, Meta Platforms Inc
Latest shares articles



